The Verdict Index

Worth it for

Mild to moderate laxity, in someone who wants a modest change, values being able to stop, and has seen the ten-year figure before starting rather than during it.

Skip it if

You are choosing non-surgical primarily because it is the affordable option. Over eighteen months that is true. Over ten years it is not, and ten years is usually the horizon people actually have in mind.

What it treats

The gap between a per-session price and a decade of them. It does not tell you which treatment suits your anatomy — that needs a provider who can see it — only what you are agreeing to pay.

Maintenance

A treatment roughly every eighteen months, indefinitely, with no finish line. The absence of a monthly bill is exactly why the total stays invisible.

Cost over time

Around 17,000 dollars over ten years for the energy routes at a mid-market rate, against 12,000 to 20,000 once for surgery. Both figures move enormously by market and by extent.

What would change this: Your own quotes, which are the only ones that matter. And durability data — if a device route were shown to hold materially longer between sessions, the decade arithmetic changes shape immediately.

Worth it for

Mild to moderate pattern hair loss, in someone who has already run minoxidil properly and alone, and who will hold a four-times-a-week schedule for five months before judging it.

Skip it if

You are buying it to make minoxidil work better. The four trials that have tested that combination did not find the addition showing up.

What it treats

Hair density in pattern hair loss. Against sham, seven randomised trials and 607 participants pooled to a standardised mean difference of 1.27 — a large effect for a consumer device, and better than the same technology can show for the face.

Maintenance

Three or four sessions a week, indefinitely. Twenty-one weeks before anything can be fairly judged. The condition is progressive, so this is upkeep rather than a course with an end.

Cost over time

279 to 2,999 dollars for cleared devices, plus a battery inside three years. The price spread is not an efficacy spread, because no two of these have ever been compared.

What would change this: One head-to-head trial. Any head-to-head trial. A category whose devices differ by a factor of 43 in diode count and 24 in session length, and none of which has been tested against another, can tell you that the idea works. It cannot tell you which one to buy.

Worth it for

Anyone comparing bottles on percentage, and anyone who concluded an acid stopped working when what actually changed was the formulation around it.

Skip it if

Anyone already using a retinoid they are still getting used to. Add one variable at a time, and let the retinoid finish introducing itself first.

What it treats

Which acid suits which problem, and why the number on the front cannot settle it. It does not tell you a strength — nothing on a cosmetic label can.

Maintenance

Its own night, at whatever frequency your skin tolerates, which is a number you can only find once nothing else is competing for the evening.

Cost over time

Ordinary. This is a category where the expensive versions are mostly buying you a nicer texture and a better vehicle, both of which are real things to buy.

What would change this: Published free-acid values and formulation pH on cosmetic labels. One line on the back of the bottle would make this entire category comparable, and its absence is the reason articles like this have to exist.

Worth it for

Someone booking a consultation who will ask which module, at what depth, coverage and number of passes, for which specific problem. The published evidence is decent and it is mode-specific, which means it only transfers to you if your protocol matches the one that was studied.

Skip it if

Anyone shopping the brand name rather than the protocol. Anyone expecting deep resurfacing results from a superficial pass, or superficial recovery from a deep one — in the published data the result and the downtime move together, which is the honest version. Laser-Coring is a separate procedure conversation, not the premium tier of a facial menu.

What it treats

Photoaging, texture, rhytides and acne scarring, at depths and coverages that differ by module. Scars are architectural, and a laser can be excellent and still not release a tethered one.

Maintenance

Courses rather than single sessions in most of the studies — commonly three treatments six to eight weeks apart, then whatever the provider recommends to hold it.

Cost over time

Resurfacing sessions run roughly 500 to 5,000 dollars depending on depth and market. Price the course and the maintenance, not the first appointment.

What would change this: Larger trials across the full Fitzpatrick range, and per-module rather than per-platform reporting. Two temporary hyperpigmentation cases appeared even in a controlled research setting, so all skin types deserves data rather than reassurance.

Worth it for

Someone who already knows they enjoy home-device routines, wants one object rather than four, and is content with incremental hydration, texture, glow and temporary definition.

Skip it if

Anyone who abandons devices once the novelty goes — the X2 does not contain a personality transplant. Anyone whose real concern is significant laxity, deep wrinkles, scarring, vascular redness or pigment that needs diagnosis. And anyone who already owns an LED mask and a microcurrent device they actually use.

What it treats

Hydration, texture, glow and temporary definition. Not dermal remodelling — and the mode percentages do not add together into it.

Maintenance

Five to ten minutes a session, up to several times daily depending on the mode, plus charging, cleaning, product pairing and an app that several features depend on.

Cost over time

229 to 299 dollars, plus an app dependency that makes this closer to consumer electronics than to a gua sha. Software support is part of how long the hardware stays useful.

What would change this: The study architecture published alongside the mode-specific percentages — sample size per endpoint, comparator, blinding, protocol, and what is left once use stops. The finished-device testing is the right instinct; it is currently ungradeable from the public page.

Worth it for

A short-needle cosmetic roller, used by someone who wants a mild exfoliation habit and holds their expectations at the level of its actual claims.

Skip it if

Anyone treating scarring at home. Anyone with a clotting or bleeding disorder, on a blood thinner, with eczema or diabetes or a compromised immune system — those are stated cautions and belong with a clinician. And anyone whose device will not tell them its needle length.

What it treats

For the cleared in-clinic procedure — facial acne scars and facial wrinkles. For the cosmetic roller, appearance and exfoliation, which is a smaller claim honestly made.

Maintenance

Cleaning between every use exactly as directed, never sharing the device, and replacing needle heads on the schedule rather than when they visibly dull.

Cost over time

10 to 40 dollars for a roller, 80 to 300 for a home pen, 200 to 700 a session in clinic. The middle option is the only one where cost and exposure point in opposite directions.

What would change this: Mandatory, plain needle-length disclosure on consumer listings. Almost every question a buyer needs answered here is answered by one number that sellers are currently free not to print.

Worth it for

Someone whose sun protection and retinoid are already in place, who wants one additional modest layer, and who will genuinely run it near-daily for months.

Skip it if

You are buying it for acne, melasma or pigment. It would be your first significant skincare purchase. Or you already own a device you stopped using — that is data about the slot, not the hardware.

What it treats

Fine lines and texture, slowly and cumulatively. Not pigment. Not acne, at home, whatever the box says.

Maintenance

No consumables, no appointments. The entire burden is time — roughly 43 hours a year at ten minutes, five nights a week.

Cost over time

400 dollars entry, nothing recurring, about 530 across three years once a battery or panel gives out.

What would change this: Independent published irradiance measurement, per model. The moment a brand lets someone else verify the dose its mask actually delivers, this stops being a judgement call and becomes arithmetic.

Worth it for

Anyone comparing bottles on percentage, anyone who has abandoned a retinoid once already, and anyone about to pay a premium for a chart that places a cosmetic next to a drug.

Skip it if

Nobody needs to skip retinoids on principle. But if you are managing acne or pigment that has not responded, the useful next step is a clinician rather than a fourth bottle.

What it treats

Which product you are actually buying, and therefore what its claim is allowed to mean. It does not tell you which one suits your face.

Maintenance

It rearranges the routine around it — a richer moisturiser, sunscreen moving from optional to non-negotiable, and acids losing their old slot. That knock-on is part of the price.

Cost over time

From a few dollars to several hundred, and the correlation with strength is close to nothing. The premium sometimes buys a vehicle you will keep using, which is a real thing to buy.

What would change this: Finished-product testing from the cosmetic lane, published and comparable. The molecule evidence has been settled for years — it is the bottle that keeps arriving unexamined.

Worth it for

Mild to moderate laxity, where the expected change fits the price and the provider can explain the device rather than recite its brand story.

Skip it if

You want structural repositioning, or you have been told that no needles means nothing can go wrong. It is a heat-based medical device and burns are possible.

What it treats

Wrinkles and laxity. Reviews report improvement across monopolar, bipolar and multipolar systems, with enough variation in settings, schedules and outcome scales that no single percentage travels well from a study to a clinic.

Maintenance

Often a single session, which is genuinely unusual in this company. The result develops gradually, so ask when the practice judges it and what would justify a repeat rather than treating annual maintenance as a subscription.

Cost over time

One appointment, and an expensive one. Price the whole horizon — treatment, travel, follow-up and a realistic repeat interval — before calling it a one-off.

What would change this: Independent comparative data rather than manufacturer-linked non-inferiority trials. Those show the category is evolving; they do not show that every monopolar system, at every clinic setting, is equivalent.

Worth it for

Mild to moderate laxity, someone who wants a bounded non-surgical change, an anatomy-literate provider, and several months of patience.

Skip it if

You need skin excised or deep structure repositioned. Nonsurgical facelift is a marketing metaphor, not a procedural equivalence.

What it treats

Modest facial and neck tightening. Reviews report investigator-rated improvement and generally good satisfaction, across studies that vary in treatment map, energy, follow-up and rating scale.

Maintenance

Remodelling develops over months, which is also what makes the before-and-after photographs so vulnerable to lighting, weight, expression and head angle.

Cost over time

One substantial session rather than a course, then a judgement about repeating. Ask when the result is assessed and what would make a repeat reasonable rather than automatic.

What would change this: Trials using a common improvement scale. One meta-analysis noted that how improvement is classified can make response rates look considerably more generous than the change on the face.

Worth it for

Selected acne scarring, with a licensed provider who can state the intended depth in each area and say whether volume loss is being avoided.

Skip it if

The practice cannot discuss the October 2025 FDA safety communication calmly, or still describes this as basically microneedling with a little heat. That communication followed reports of burns, scarring, fat loss, disfigurement and nerve damage, some requiring medical or surgical intervention.

What it treats

Acne scars, wrinkles, laxity and texture, on a heterogeneous literature: devices, needle configurations, parameters and outcome scales all vary, and some recent reviews carry device-industry affiliations.

Maintenance

A series, then a judgement. Ask what is expected, what is not, and who is medically responsible after hours. Send us a photo if you are worried is not an emergency plan.

Cost over time

Priced per session and quoted as a course. The complication pathway is part of what you are buying, and it never appears on the price list.

What would change this: A clean population-level complication rate. Adverse-event reporting can identify a serious signal and cannot supply a denominator — which is an argument for better consent and follow-up, not for ignoring the signal.

Worth it for

A clearly defined light-responsive target — vessels, diffuse redness, sun-related lentigines — with a provider who routinely treats your skin tone on that exact platform.

Skip it if

Melasma, or any pigment change that has not actually been diagnosed. Pigment is not a one-word diagnosis, and heat and light can aggravate melasma in some people.

What it treats

Selected vascular and photodamage findings. A systematic review of 16 studies and 637 participants found improvement — and judged nine of those studies low methodological quality, with no consensus on treatment parameters.

Maintenance

A series, then upkeep, and a calendar that steers around the beach fortnight. Recent tanning changes how much melanin is available to absorb the light.

Cost over time

Price the course rather than the promotional session, and leave room for a pigment-management visit. It is a real possibility and it belongs in the figure.

What would change this: Consensus treatment parameters, and trials that are not judged low quality. Also better phototype representation, since pigment risk is the central concern here and darker skin is where the published evidence is thinnest.

Worth it for

Photoaging and uneven tone, if you will finish the bottle before it finishes itself. The serum you actually use beats the one you respect from a distance.

Skip it if

This would be the fourth one in the drawer, or the whole case for it rests on a percentage and nothing else.

What it treats

Photodamage, wrinkles and pigmentation, on a small and heterogeneous evidence base that supports benefit without promising a new face.

Maintenance

Daily, and replaced on the schedule the formula needs rather than the one your budget would prefer. Ascorbic acid degrades whether or not you are finished with it.

Cost over time

The premium is largely packaging and stability engineering. That is a reasonable thing to pay for and a poor thing to mistake for proof.

What would change this: Comparative trials between forms. Most of the classic work used L-ascorbic acid, and the phrase vitamin C is not a wire transfer that moves those results into every derivative sharing the family name.

Worth it for

Someone with sun protection and a retinoid already in place, who knows this is a cosmetic rather than a treatment, likes the category on its own terms, and can absorb a repeat purchase without resenting it.

Skip it if

Anyone buying it because growth factors sound medical. Anyone whose sunscreen is still occasional — the same money does far more work there. Anyone with irritation they have not yet traced to a source.

What it treats

A general appearance claim within the growth-factor category. Not a specific, isolated, demonstrated effect from this bottle.

Maintenance

A premium repeat purchase, indefinitely, with no endpoint and no moment at which the result is banked.

Cost over time

295 dollars a bottle. Work out the bottles-per-year figure before the first one rather than after the third.

What would change this: A trial of the serum alone, against a credible comparator, with the professional treatments taken out. The strongest study available tested it inside a multi-step protocol, so it cannot separate the product from everything else in the protocol.

Worth it for

A specific structural problem, treated with a product chosen for that job, by an injector who can name the cause they are trying to influence.

Skip it if

The plan grows every visit because balance can always be improved. A treatment plan should be allowed to end before the menu does.

What it treats

Volume and projection. It is not equally good at dynamic lines, texture, pigment or laxity, and separating those at the consultation is most of the work.

Maintenance

Reassessment rather than a refill date. Absorption varies by product and person, and the right interval is not automatically the one the calendar suggests.

Cost over time

A syringe at a time, indefinitely, unless somebody stops. Run the multi-year figure before treating the first appointment as the price.

What would change this: Nothing about the material. What changes a given plan is whether the injector can state the emergency protocol for a suspected vascular occlusion out loud — the FDA warns that inadvertent intravascular injection can cause tissue necrosis, visual impairment including blindness, or stroke.

Worth it for

Skin that feels tight and dehydrated, when a standalone bottle visibly does something your moisturiser is not.

Skip it if

Hyaluronic acid is already sitting in half the moisturisers you own. If yours handles comfort, the new dropper is a second layer and a recurring charge.

What it treats

Surface hydration, comfort, and temporary optical smoothing. Not placement, not volume, not structural lift — those belong to the injectable, which is a different product with its own evidence file.

Maintenance

Daily, and only while you keep using it. Hydration is a state, not an achievement.

Cost over time

Anywhere from trivial to absurd, depending largely on how many hyaluronans the box has counted for you. The count is not an endpoint.

What would change this: Finished-product penetration data rather than a molecule-size graphic. A blend of eight weights is a formulation choice, not a result.

Worth it for

A job you can name — visible oiliness, barrier support, signs of photoaging — at a concentration you can tolerate every day.

Skip it if

You are reaching for 20 per cent because 10 did not work. Four times the concentration is not four times the result, and most of the familiar studies live between 2 and 5 per cent.

What it treats

Three separate questions that keep being merged into one: 2 per cent for sebum, 4 per cent in inflammatory acne, 5 per cent for visible aging. Different trials, different outcomes, one word on the box.

Maintenance

Daily, and largely invisible — it is already in the cleanser, the moisturiser and the sunscreen whether you decided that or not.

Cost over time

Cheap in every form, which makes the high-percentage premium difficult to defend on anything except the number itself.

What would change this: Finished-product data at the high concentrations. A manufacturer may hold some. The percentage printed on the front is not it.

Worth it for

A barrier under load — real dryness, low humidity, frequent washing, or a routine full of irritating actives.

Skip it if

You are choosing it over a plain emollient purely because the box lists three ceramide names. One randomised trial found that using a moisturiser regularly mattered more than which one you used.

What it treats

Barrier lipids: the mortar between cells, alongside cholesterol and free fatty acids. Architecture rather than moisture, which is the whole distinction.

Maintenance

Twice daily, generously, indefinitely. The usual failure is using too little of something too expensive to use properly.

Cost over time

Whatever you allow it to be. There is no evidence premium attached to the word, so the money should be buying texture and tolerance instead.

What would change this: Finished-formula testing behind a lipid-architecture claim. You cannot reconstruct a 3 to 1 to 1 ratio or its lamellar organisation from an ingredient list, however long you squint at it.

Worth it for

Very dry skin that likes a heavy occlusive, tolerates it, and is buying the texture rather than the mythology.

Skip it if

Acne-prone skin volunteering as proof of concept, and anyone with diagnosed eczema or psoriasis being invited to swap a treatment plan for a balm.

What it treats

Dryness. It behaves like a rich emollient and occlusive, which is a respectable job that does not need a family tree.

Maintenance

A jar, applied thinly. The only real upkeep questions are oxidation and how the formula is preserved if it contains water.

Cost over time

Anywhere from trivial to a small amber jar priced as though the cow had a trust fund. The price only becomes wrong when the claim inflates.

What would change this: Controlled human trials of finished tallow products for the conditions being claimed. The 2024 scoping review asked for exactly that and reported it missing.

Worth it for

Melasma or persistent hyperpigmentation where a non-hydroquinone route is wanted, at 5 per cent, with serious photoprotection running alongside it.

Skip it if

You want a general glow. Pigment is several different problems wearing one word, and this is aimed at one of them.

What it treats

Melasma. Several randomised trials put topical 5 per cent close to hydroquinone over about twelve weeks. One split-face trial found it no better than vehicle, and that disagreement belongs in the decision.

Maintenance

Months rather than weeks, plus daily sunscreen — pigment recurs, and UV keeps feeding it whatever the serum is doing.

Cost over time

Moderate, and what you are buying is a protocol rather than a product. The sunscreen is the line people underspend on.

What would change this: Finished-product trials on the lower-strength blends. Evidence from microneedling-assisted delivery does not transfer to a plain leave-on, and a 5 per cent study does not validate a 2 per cent one.

Worth it for

Anyone who has genuinely failed retinoids on irritation and would rather use a gentler bottle every night than a stronger one twice a month.

Skip it if

You tolerate a retinoid perfectly well. You would be trading a large evidence base for a small one and usually paying more for the privilege.

What it treats

Wrinkle surface area and hyperpigmentation, on one clean twelve-week head-to-head against 0.5 per cent retinol.

Maintenance

Twice daily in the trial that matters, and held long enough for a twelve-week window to mean anything.

Cost over time

Priced like a premium active while carrying a fraction of the literature. That gap is the thing worth noticing.

What would change this: Larger blinded trials that are not open-label and not combination formulas. Separately, human pregnancy-safety data, which does not exist and is not implied by the molecule simply not being a retinoid.

Worth it for

Skin that will not tolerate a stripping active, and wound or post-procedure use under professional direction.

Skip it if

You are buying it as the acne treatment. Benzoyl peroxide, a topical retinoid and salicylic acid have far stronger receipts for that particular job.

What it treats

Adjunctive antimicrobial cleansing. The acne trial people quote at you studied sodium hypochlorite, which is a related chemistry and a different evidence object.

Maintenance

Almost none, and that is honestly part of the appeal. No ramp-up, no schedule, nothing to build tolerance to.

Cost over time

Small per bottle and very easy to keep buying. The risk here is not the price, it is the slot it occupies instead of something that treats.

What would change this: Direct human trials of stabilised hypochlorous acid facial sprays for acne. The strong human record at present is antisepsis, not therapy.

Worth it for

A defined target, someone who can wait out a gradual result without demanding a top-up because nothing has happened yet, and who will actually do the aftercare massage.

Skip it if

Reversibility matters to you. There is no hyaluronidase equivalent here, so we can dissolve it tomorrow is not available as the default corrective story.

What it treats

Fine lines and wrinkles in the cheek region on label since April 2023, plus the earlier facial wrinkle and contour indications. Other patterns are off-label, which should make the explanation more precise rather than vaguer.

Maintenance

A staged series in which each session should be a fresh decision rather than a prepaid obligation, plus gentle massage several times a day for one to two weeks.

Cost over time

The first vial price is a particularly poor measure of it. Cost the planned series, the follow-up, any added sessions and the clinic maintenance philosophy.

What would change this: Nothing about the mechanism. What should change a given plan is hearing a formula like one vial per decade of age in the consultation — that is sales shorthand, not physiology.

Worth it for

Anyone about to let one word carry them from a 20-dollar serum to a syringe. That distinction is the entire decision.

Skip it if

Nobody — but note that skin booster is a marketing genre rather than a regulatory category, so the phrase on its own tells you almost nothing.

What it treats

Route. A topical hydrates the surface. An intradermal injection changes selected skin-quality measures. A filler creates physical projection at a chosen plane. All three can produce a smoother photograph, by entirely different roads.

Maintenance

Escalates sharply with route: daily for the serum, a schedule for the booster, a repeat interval plus a provider relationship for filler.

Cost over time

From 20 dollars to several hundred a syringe — and the risk profile scales faster than the price does.

What would change this: Nothing about the principle. What changes for any given product is whether its evidence came from the same route it is being sold in. There is no carrying a balance across.

Worth it for

Someone who knows the annual range, can carry it without quiet resentment, and wants a modest result maintained on purpose.

Skip it if

The only figure you have is a per-unit teaser, the plan grows every visit without being agreed, or the word preventative is covering a spend you cannot sustain.

What it treats

The arithmetic the menu leaves incomplete. Per-unit pricing without expected units is not a price, and 350 dollars an area for three areas three times a year is 3,150 dollars.

Maintenance

Three to four sessions a year, indefinitely. The effect is temporary by design, which makes the calendar the product.

Cost over time

An illustrative 2,000-dollar maintenance year is 6,000 over three years and 10,000 over five — before price rises, and before while we are here quietly adds an area.

What would change this: Nothing about the arithmetic. What changes your number is your own dose, interval and market, so run the proposal you were actually handed rather than a national range.

Worth it for

Someone who has found the specific model with its own published protocol and its own trial, and will run exactly that protocol rather than an approximation of it.

Skip it if

Anyone shopping the category instead of the model. A clinic system generates results a handset borrowed the vocabulary from, and that is the whole trick — the evidence does not travel with the word.

What it treats

Modest facial rejuvenation, under a defined protocol, on the devices that were actually studied. Not on the ones that merely share a name for the technology.

Maintenance

The protocol is the product: session length, frequency and schedule. Off-protocol use is not a smaller version of the result, it is a different thing that has not been tested.

Cost over time

Purchase price divided by the sessions you actually complete. At the schedule on the box it looks cheap. At the schedule people keep, it usually is not.

What would change this: Independent head-to-head trials by model rather than by category, so a buyer could compare the object in front of them instead of the claim standing behind it.

Worth it for

Someone who wants a better-looking face on a particular evening and will keep the schedule to get it. Bought as an occasion tool, it delivers.

Skip it if

Anyone buying a permanent lift in a rechargeable handle. Anyone who will not hold a near-daily protocol. And anyone with implanted electronics or an active skin condition — that one is a question for the manual and a clinician, not a preference.

What it treats

Short-term tone and contour, on the day. Not structural change, and not something that accumulates into one.

Maintenance

Frequent sessions plus conductive gel you keep re-buying. The effect ends when the schedule does — that is the mechanism, not a flaw in your technique.

Cost over time

The handle is bought once. The gel is a subscription with better manners. Work out your own gel-per-year figure before the handle, not after.

What would change this: A controlled trial that follows people past the point where they stop, and measures what is left. Everything currently on offer measures people while they are still doing it.

Worth it for

A stable routine, a formula you enjoy, and a product whose evidence you can trace to the actual sequence or the finished formula.

Skip it if

You are expecting injection-like change, or paying a premium because the page carries enough molecular vocabulary to feel medically important.

What it treats

Skin-aging outcomes at category level — a 2026 systematic review and meta-analysis of randomised trials supports that much. It does not make the products interchangeable.

Maintenance

Daily and indefinite, which is exactly what makes the annual figure more revealing than the bottle price.

Cost over time

A 90-dollar bottle that lasts eight weeks is roughly 585 dollars a year. Fine for a formula you love. Harder to defend when the hydration job is already covered elsewhere.

What would change this: Finished-formula testing rather than raw-material studies, with immediate smoothing separated from longer-term structural claims. Watch for the sentence that switches from the retail product to a supplier study halfway through.

Worth it for

Someone with one outcome in mind who can find wavelength, irradiance and treatment time for the exact model — and who will still be using it in month four.

Skip it if

The product page leads with a celebrity face and an LED count. Bulb count describes coverage, not the dose that reaches skin.

What it treats

Photobiomodulation for named endpoints: wrinkle appearance, inflammatory acne, redness. A device can combine wavelengths and still have far better evidence for one of them than the others.

Maintenance

Ten minutes sounds small until it is several evenings a week for months. Adherence is an efficacy question, not a character one.

Cost over time

Vacation money for a plastic shell, paid once. What it costs per use depends entirely on whether it keeps leaving the drawer.

What would change this: Human evidence on the exact model, or a technically equivalent predecessor, for the outcome being sold. A professional panel study makes a consumer device plausible; it does not finish the proof.